Connecting - News - Information
Thursday 6 December 2018
PHASE 2 INTERIM DATA EVALUATING THE COMBINATION OF PRACINOSTAT AND AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME PRESENTED AT THE 2018 AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING
PHASE 2 INTERIM DATA EVALUATING THE COMBINATION OF PRACINOSTAT AND AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME PRESENTED AT THE 2018 AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment